Imaging folate binding protein expression with MRI.

[1]  P. Low,et al.  Folate-mediated targeting: from diagnostics to drug and gene delivery. , 2001, Drug discovery today.

[2]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[3]  E C Wiener,et al.  Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress. , 2000, Investigative radiology.

[4]  W. Gunning,et al.  Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  J. Holm,et al.  High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity. , 1999, Archives of biochemistry and biophysics.

[6]  L. Jacobsson,et al.  Biokinetics of the monoclonal antibodies MOv 18, OV 185 and OV 197 labelled with 125I according to the m-MeATE method or the Iodogen method in nude mice with ovarian cancer xenografts. , 1999, Acta oncologica.

[7]  P. Low,et al.  Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  S. Nielsen,et al.  Internalization and apical-to-basolateral transport of folate in rat kidney proximal tubule. , 1997, The American journal of physiology.

[9]  S. Ménard,et al.  Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19. , 1994, European journal of cancer.

[10]  V. Zurawski,et al.  Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. , 1992, Cancer research.

[11]  L R Coney,et al.  Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.

[12]  J. Hjelle,et al.  Cell fractionation and electron microscope studies of kidney folate-binding protein. , 1991, The American journal of physiology.

[13]  S. Ménard,et al.  Immunohistochemical Reactivity of a Monoclonal Antibody Prepared against Human Ovarian Carcinoma on Normal and Pathological Female Genital Tissues , 1989, Tumori.